Filing Details
- Accession Number:
- 0001225208-18-008924
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-08 17:17:11
- Reporting Period:
- 2018-05-07
- Accepted Time:
- 2018-05-08 17:17:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1566080 | J. Kevin Ballinger | 300 Boston Scientific Way Marlborough MA 01752-1234 | Evp & Pres, Interven Cardio | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-05-07 | 31,056 | $7.16 | 102,207 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-05-07 | 31,056 | $30.00 | 71,151 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2018-05-07 | 31,056 | $0.00 | 31,056 | $7.16 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
31,056 | 2021-02-28 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- Grant to the reporting person of an option to purchase 62,112 shares of common stock vesting in four annual increments beginning on February 28, 2012, the first anniversary of the grant.